Catherine Larue

Catherine Larue

Direttore/Membro del Consiglio presso GENFIT
70 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Catherine Larue is currently an Independent Director at Genfit SA, a Director at Fondation Arc en Ciel, and a Director at ITTM SA. Previously, she served as the Chief Executive Officer at Integrated Biobank of Luxembourg from 2012 to 2015 and at Luxembourg Institute of Health from 2016 to 2017.
She also held positions as a Director-Business Unit at Bio-Rad Laboratories, Inc. and as a Director-Research & Development at Sanofi Diagnostics Pasteur, Inc. In 2019 to 2020, she was the Director-External Affairs at Integrated Biobank of Luxembourg.
Currently, she is also an Independent Director at Quotient Ltd. In addition to her professional experience, Dr. Larue holds an MBA from St. John's University, a graduate degree from The International School of Management, and a doctorate from Université de Rouen Normandie.

Posizioni attive di Catherine Larue

SocietàPosizioneInizio
GENFIT Direttore/Membro del Consiglio 16/06/2017
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Catherine Larue

SocietàPosizioneFine
QUOTIENT LIMITED Direttore/Membro del Consiglio 16/02/2023
Corporate Officer/Principal 01/01/2020
Amministratore Delegato 01/01/2017
Amministratore Delegato 01/01/2015
BIO-RAD LABORATORIES, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Catherine Larue

Formazione di Catherine Larue

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

22

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Consumer Services

Health Technology

Consumer Services

Sanofi Diagnostics Pasteur, Inc.

Consumer Services

Health Services

Health Technology

Commercial Services

Commercial Services

Technology Services

  1. Mercati
  2. Insiders
  3. Catherine Larue
- 40% : I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA